Psoriatic skin inflammation induces a pre-diabetic phenotype via the endocrine actions of skin secretome

Abstract

Objective Psoriasis is a chronic inflammatory skin disease that is thought to affect ∼2% of the global population. Psoriasis has been associated with ∼30% increased risk of developing type 2 diabetes (T2D), with numerous studies reporting that psoriasis is an independent risk-factor for T2D, separate from underlying obesity. Separately, studies of skin-specific transgenic mice have reported altered whole-body glucose homeostasis in these models. These studies imply a direct role for skin inflammation and dysfunction in mediating the onset of T2D in psoriasis patients, potentially via the endocrine effects of the skin secretome on key metabolic tissues. We used a combination of in vivo and ex vivo mouse models and ex vivo human imiquimod (IMQ) models to investigate the effects of psoriasis-mediated changes in the skin secretome on whole-body metabolic function. Methods To induce psoriatic skin inflammation, mice were topically administered 75 mg of 5% IMQ cream (or Vaseline control) to a shaved dorsal region for 4 consecutive days. On day 5, mice were fasted for glucose and insulin tolerance testing, or sacrificed in the fed state with blood and tissues collected for analysis. To determine effects of the skin secretome, mouse skin was collected at day 5 from IMQ mice and cultured for 24 h. Conditioned media (CM) was collected and used 1:1 with fresh media to treat mouse explant subcutaneous adipose tissue (sAT) and isolated pancreatic islets. For human CM experiments, human skin was exposed to 5% IMQ cream for 20 min, ex vivo , to induce a psoriatic phenotype, then cultured for 24 h. CM was collected, combined 1:1 with fresh media and used to treat human sAT ex vivo . Markers of tissue inflammation and metabolic function were determined by qPCR. Beta cell function in isolated islets was measured by dynamic insulin secretion. Beta-cell proliferation was determined by measurement of Ki67 immunofluorescence histochemistry and BrDU uptake, whilst islet apoptosis was assessed by caspase 3/7 activity. All data is expressed as mean ± SEM. Results Topical treatment with IMQ induced a psoriatic-like phenotype in mouse skin, evidenced by thickening, erythema and inflammation of the skin. Topical IMQ treatment induced inflammation and signs of metabolic dysfunction in sub-cutaneous and epidydimal adipose tissue, liver, skeletal muscle and gut tissue. However, consistent with islet compensation and a pre-diabetic phenotype, IMQ mice displayed improved glucose tolerance, increased insulin and c-peptide response to glucose, and increased beta cell proliferation. Treatment of sAT with psoriatic mouse or human skin-CM replicated the in vivo phenotype, leading to increased inflammation and metabolic dysfunction in mouse and human sAT. Treatment of pancreatic islets with psoriatic mouse skin-CM in...

Transcriptomic Analysis of the Mechanisms for Alleviating Psoriatic Dermatitis Using Taodan Granules in an Imiquimod-Induced Psoriasis-like Mouse Model

“…Several studies ( Gelfand et al, 2018 ; Tollefson et al, 2018 ; Evans et al, 2020 ) have shown that the pathogenesis of psoriasis is closely related to metabolic disorders that are frequently aggravated. The Gly-Ser-Thr axis is a major metabolic crossroad connecting several crucial biological pathways ( Aon et al, 2020 ).…”

Target molecules for future hidradenitis suppurativa treatment

“…Obesity is known to promote a proinflammatory state, which facilitates the manifestation of inflammatory skin diseases 70 . In contrast, inflammatory skin diseases, such as imiquimod‐induced psoriasis‐like lesions in mice, can induce reactions in pancreatic beta islet cells mimicking a prediabetic phenotype 71 . In this context, the first‐line antidiabetic biguanide metformin appears as a model‐drug in HS treatment 72,73 , affecting various indirect and direct pathways of inflammation or steroid receptor signalling, both in immune and epithelial cells 74 .…”

Psoriasis Exacerbates the State of Insulin Resistance in Patients with Type 2 Diabetes

“…Similar findings were reported by a study that used a mice model of psoriasis-like skin inflammation, which showed that a pre-diabetic phenotype displayed by compensating function of pancreas, and signs of metabolic dysfunction in subcutaneous and other multiple organs. 29 This preliminary study only reports the general distributions of glucose metabolic diversity between normal T2D patients and T2D with PsO in our hospital, therefore, there is need to explore the underlying molecular and genetic mechanism of PsO on the pathophysiology of T2D.…”